awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38063170-5496D13A-0C7A-4A73-ADC6-5DB9E40F7C98
Q38063170-5496D13A-0C7A-4A73-ADC6-5DB9E40F7C98
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38063170-5496D13A-0C7A-4A73-ADC6-5DB9E40F7C98
What do we do with chronic lymphocytic leukemia with 17p deletion?
P2860
Q38063170-5496D13A-0C7A-4A73-ADC6-5DB9E40F7C98
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38063170-5496D13A-0C7A-4A73-ADC6-5DB9E40F7C98
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b5fd75a91eac4161341d2cba7502b5d6cdefca1a
P2860
Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.